Skip to main content
Clinical Trials/JPRN-jRCT2080221626
JPRN-jRCT2080221626
Unknown
Phase 2

An exploratory study to assess the efficacy and safety of NS-304 in patients with chronic thromboembolic pulmonary hypertension (CTEPH)

IPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.0 sites32 target enrollmentOctober 18, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic thromboembolic pulmonary hypertension (CTEPH)
Sponsor
IPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.
Enrollment
32
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
IPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.

Eligibility Criteria

Inclusion Criteria

  • CTEPH patient as demonstrated the deficit of lung perfusion by ventilation/perfusion lung scanning and pulmonary angiography

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Exploratory study to evaluate the efficacy and safety of nutritionally administering 1.5 g protein/kg/day vs. 1.0 g protein/kg/day in the catabolic phase of the critically ill patient on mechanical ventilatioAcquired Weakness in the Intensive Care Unit (DAUCI) of the critically ill patient.MedDRA version: 20.0Level: PTClassification code 10077255Term: Intensive care unit acquired weaknessSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Not possible to specify
EUCTR2021-002329-56-ESSociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)200
Recruiting
Not Applicable
Exploratory study to evaluate the efficacy and safety of tocilizumab for Takayasu's arteritis based on classification by type of autoantibody
JPRN-jRCTs021210077Ishii Tomonori20
Not yet recruiting
Not Applicable
The exploratory study for the efficacy and the safety of Rikkunshito on symptoms of indigestion in the patients with Functional HeartburFunctional Heartburn
JPRN-UMIN000029668ippon Medical School Graduate School of Medicine20
Completed
Not Applicable
The exploratory study for the efficacy and the safety of Hangeshashinto on symptoms of heartburn /belch in the patients with gastroesophageal reflux disease (GERD)GERD
JPRN-UMIN000021251Osaka Medical College80
Completed
Not Applicable
The exploratory study for the efficacy and the safety of Daikenchuto(TJ-100) on abdominal pain and abdominal fullness feeling in the patients with fecal incontinence.Abdominal pain and abdominal fullness feeling in the patients with fecal incontinence
JPRN-UMIN000030252Medical Corporation Seiaikai, Gion Usshita Hospital50